A 51-year-old man after esophagectomy for distal esophageal cancer developed severe gastroparesis. His symptoms of gastroesophageal reflux, chest pain, early satiety, and fullness in the chest were persistent despite medical treatment. An esophagogastroduodenoscopy (EGD) with pyloric botulinum toxin injection with a balloon dilation resulted in "\>80%" symptomatic benefit for 3 months with relapse of significant symptoms thereafter. On repeat EGD, food was found in the gastric body despite the patient being fasting consistent with delayed gastric emptying. The pylorus looked normal but appeared to contract "vigorously" suggesting pylorospasm \[[Figure 1](#F1){ref-type="fig"}\]. A linear echoendoscope was passed to the duodenum bulb where the normal duodenal wall thickness was 2 mm (normal) \[[Figure 2](#F2){ref-type="fig"}\]. As the echoendoscope was withdrawn to the level of the pylorus at the pyloric sphincter, it revealed a stark change with a thickness of 7--8 mm. A 25G endoscopic ultrasound-guided fine-needle aspiration needle was inserted into the muscular region of the pyloric sphincter deeper to the mucosa/submucosa but superficial to serosa. The pyloric sphincter was precisely injected with a total 100 U (25 U/mL in 4 quadrants) of botulinum toxin \[[Figure 3](#F3){ref-type="fig"}\] followed by pyloric balloon dilation to 20 mm, without immediate or delayed adverse effects. The patient again had significant response to treatment which lasted for twice the duration for 6 months.

![Pyloric sphincter seen during EGD that looked normal but appeared to contract vigorously during endoscopy suggesting pylorospasm](EUS-8-350-g001){#F1}

![Normal duodenal bulb wall by EUS with a thickness of about 2 mm](EUS-8-350-g002){#F2}

![The pyloric sphincter as seen by EUS with total thickness of 7--8 mm with the needle implanted under EUS guidance in the muscularis propria](EUS-8-350-g003){#F3}

The standard technique of botulinum toxin injection into the pylorus is done during EGD with an injection needle without any additional imaging guidance.\[[@ref1][@ref2]\] The drug may be delivered mostly in the submucosa or only partly into the muscularis propria. A technique for more precise delivery of the drug to the muscularis propria could potentially improve the duration (as seen in this patient) and degree of response. Further prospective studies of this technique would be worthwhile.
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